Lincoln Capital Corp Grows Stake in CVS Health Corp (CVS)

Lincoln Capital Corp lifted its position in CVS Health Corp (NYSE:CVS) by 88.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 45,209 shares of the pharmacy operator’s stock after buying an additional 21,205 shares during the period. CVS Health makes up about 3.3% of Lincoln Capital Corp’s investment portfolio, making the stock its 15th biggest position. Lincoln Capital Corp’s holdings in CVS Health were worth $3,676,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Horan Capital Advisors LLC. boosted its stake in shares of CVS Health by 3.2% in the 2nd quarter. Horan Capital Advisors LLC. now owns 32,115 shares of the pharmacy operator’s stock worth $2,584,000 after buying an additional 1,000 shares during the last quarter. Community Bank N.A. boosted its stake in shares of CVS Health by 7.3% in the 2nd quarter. Community Bank N.A. now owns 19,976 shares of the pharmacy operator’s stock worth $1,608,000 after buying an additional 1,362 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its stake in shares of CVS Health by 3.2% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 176,294 shares of the pharmacy operator’s stock worth $13,840,000 after buying an additional 5,478 shares during the last quarter. Midwest Investment Management LLC raised its holdings in CVS Health by 6.2% in the 2nd quarter. Midwest Investment Management LLC now owns 21,382 shares of the pharmacy operator’s stock worth $1,720,000 after purchasing an additional 1,245 shares during the period. Finally, Fiduciary Trust Co. raised its holdings in CVS Health by 1.2% in the 1st quarter. Fiduciary Trust Co. now owns 366,007 shares of the pharmacy operator’s stock worth $28,732,000 after purchasing an additional 4,265 shares during the period. Hedge funds and other institutional investors own 82.24% of the company’s stock.

Shares of CVS Health Corp (NYSE:CVS) opened at $73.08 on Monday. The company has a current ratio of 1.05, a quick ratio of 0.55 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $74,029.46, a PE ratio of 12.80, a price-to-earnings-growth ratio of 1.37 and a beta of 0.89. CVS Health Corp has a twelve month low of $66.45 and a twelve month high of $84.72.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Monday, November 6th. The pharmacy operator reported $1.50 EPS for the quarter, beating the Zacks’ consensus estimate of $1.49 by $0.01. The business had revenue of $46.18 billion for the quarter, compared to analysts’ expectations of $46.17 billion. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The business’s quarterly revenue was up 3.5% on a year-over-year basis. During the same period last year, the firm earned $1.64 earnings per share. equities research analysts predict that CVS Health Corp will post 5.9 EPS for the current year.

A number of equities analysts recently commented on the company. Royal Bank of Canada assumed coverage on CVS Health in a report on Tuesday, September 19th. They issued an “outperform” rating and a $95.00 target price on the stock. Jefferies Group raised their target price on CVS Health from $82.00 to $86.00 and gave the stock a “hold” rating in a report on Friday, September 15th. Needham & Company LLC reaffirmed a “hold” rating on shares of CVS Health in a report on Sunday, September 10th. Oppenheimer reaffirmed a “buy” rating and issued a $95.00 target price on shares of CVS Health in a report on Monday, October 9th. Finally, Mizuho set a $90.00 target price on CVS Health and gave the stock a “buy” rating in a report on Tuesday, October 24th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and fifteen have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $86.35.

In other CVS Health news, EVP Thomas M. Moriarty sold 20,547 shares of the firm’s stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $81.17, for a total transaction of $1,667,799.99. Following the sale, the executive vice president now directly owns 43,178 shares of the company’s stock, valued at $3,504,758.26. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.61% of the stock is owned by company insiders.

TRADEMARK VIOLATION WARNING: “Lincoln Capital Corp Grows Stake in CVS Health Corp (CVS)” was reported by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this news story on another publication, it was copied illegally and republished in violation of international copyright law. The original version of this news story can be viewed at https://www.thelincolnianonline.com/2017/12/18/lincoln-capital-corp-grows-stake-in-cvs-health-corp-cvs.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply